07 Dec Potential Missing Professional Information (PI) and Patient Information Leaflet (PIL) in Folding Boxes of Pertjeta® 420 mg/14 mL infusion (pertuzumab)
Posted at 09:24h
in
Dear Healthcare Professional
In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Products (Pty) Ltd would like to inform you of the potential missing PI and PIL in folding boxes of Perjeta® (pertuzumab) 420mg/14mL infusion.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
30/11/2023
File Type:
pdf
Category:
Communication To Health Care Professionals